Ton Shen Health/Life Rising Expands Recalls of "DHZC-2 Tablet" to All Lots Purchased Before August 24 2016 Because of Possible Health Risk

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Ton Shen Health/Life Rising Expands Recalls of "DHZC-2 Tablet" to All Lots Purchased Before August 24 2016 Because of Possible Health Risk

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

 

Ton Shen Health/Life Rising Expands Recalls of “DHZC-2 Tablet” to All Lots Purchased Before August 24 2016 Because of Possible Health Risk

08/30/2016 02:11 PM EDT

Ton Shen Health/Life Rising Corporation of Chicago, IL, is expanding its recall of "DHZC-2" Tablets to all lots purchased before August 24, 2016 because they have the potential to be contaminated with elevated levels of lead.

For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? Please visit subscriberhelp.govdelivery.com
• Other inquiries? webmail@xxxxxxxxxx

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)